Neurogen Corp (NASDAQ:NRGN)

CAPS Rating: No stars

A drug discovery & development company focusing on new small molecule drugs to improve the lives of patients suffering from disorders with unmet medical need including insomnia, obesity, pain, Parkinson's disease, Restless Legs Syndrome & depression.

Results 1 - 2 of 2

Recs

0
Member Avatar DiscoJohn (99.80) Submitted: 3/24/2008 10:21:25 PM : Underperform Start Price: $6.38 NRGN Score: +97.00

Maybe people are a little unclear as to why there is absolutely no prospect for success with this stock: Restless Leg Syndrome. If you're gullible enough to think you have restless leg syndrome, fine, invest away.

Report this Post 2 Comments | Reply | Permalink

Recs

0
Member Avatar Steve4321 (< 20) Submitted: 9/4/2007 10:49:28 PM : Outperform Start Price: $5.05 NRGN Score: -90.21

The pipeline is starting to look good.

Report this Post Reply | Reply | Permalink
Results 1 - 2 of 2

Featured Broker Partners


Advertisement